DATATRAK International, Inc.
$0.30$0.00 (0.0%)
DATATRAK International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.3% below the high.
OTC · CHME · USD
Stock price
Quote as of Oct 29, 2026, 07:24 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
China Medicine Corp.’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:35 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.30$0.00 (0.0%)
DATATRAK International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.3% below the high.
$0.06+$0.01 (+11.98%)
CTT Pharmaceutical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.1% below the high.
$0.04$0.00 (0.0%)
Telesis Bio, Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.27% below the high.
$0.18$0.00 (0.0%)
Procyon Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
$0.06$0.00 (0.0%)
Unity Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.19% below the high.
€0.87€0.00 (0.0%)
Epigenomics AG’s quoted price sits in the lower half of its reported 52-week range, 45.28% below the high.
$0.00$0.00 (0.0%)
PPJ Healthcare Enterprises, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.01$0.00 (0.0%)
Ovation Science Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.13% below the high.